June 9, 2009 4:16 PM

Small Cap News Movers for 6/9/09

comments 0
MDRNA, Inc. (NASDAQ: MRNA) announced that it has obtained full U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for generic calcitonin-salmon nasal spray for the treatment of osteoporosis. The company also announced that Par Pharmaceutical Companies, Inc. (NYSE: PAR) has launched the product. "Revenue generated from the sale of calcitonin-salmon by Par will provide us with working capital to help advance our RNAi programs," stated J. Michael French, President and CEO of MDRNA. The stock closed at $2.70, up 75.32%, on 14,526,850 traded shares.
 
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced that it has received CE Mark approval for its KS-X Preloaded Hydrophobic Acrylic Injector for use in minimally invasive cataract surgical procedures. The CE Mark allows STAAR Surgical to market this foldable intraocular (IOL) KS-X lens delivery system in the European Union as well as other countries that recognize the CE Mark. The stock closed at $1.58, up 46.30%, on 1,237,513 traded shares.
 
Akeena Solar (NASDAQ: AKNS) announced yesterday that it was honored with the Solar Energy Industries Association Industry Innovator Award for its new Andalay AC solar panel system. The award recognizes companies who have made key contributions to the industry through continual technological innovation and coincided with the release of a white paper detailing the technical advantages of Akeena's new Andalay AC solar panels, the first plug-and-play solar system. The stock closed at $1.48, up 22.31%, on 2,400,271 traded shares.
 
 
 
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future.

 

Add your comments

Name:

Your comments:

E-Newsletters

We value your privacy. Your email address will not be shared.